SEC Form 4 · accession 0001871423-26-000010
Rani Therapeutics Holdings, Inc. · RANI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas Maestas
Officer — Chief Financial Officer
Period of report
Jul 17, 2026
Accepted (ET)
Jul 21, 2026 · 4:51 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001856725
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.6973 | Jul 17, 2026 | A | 2,000,000 | A | — | Jul 16, 2036 | Class A Common Stock | 2,000,000 | 2,000,000 | D |
Explanation of responses
- F1The shares subject to the option vest as follows: 25% of the shares subject to the option vests on June 29, 2027; and 1/48th of the shares subject to the option vest monthly thereafter over the remaining three years, subject to the Reporting Person's Continuous Service (as defined in the Company's 2026 Inducement Plan) through each such vesting date.